Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Fierce Pharma
Tue, 11/24/20 - 11:23 pm
DexCom
DTC advertising
diabetes
type 2 diabetes
blood glucose monitoring
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Tue, 09/1/20 - 10:44 am
Novo Nordisk
UK
type 2 diabetes
diabetes
Rybelsus
semaglutide
NICE
Study: Type 2 Diabetes Treatments May Be More Effective When Combined
BioSpace
Sun, 08/30/20 - 11:27 pm
diabetes
type 2 diabetes
FGF21
GLP-1 agonist
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
Fierce Pharma
Sun, 06/14/20 - 08:06 pm
ADA
diabetes
Sanofi
Soliqua
type 2 diabetes
Fractyl Seeks to Turn Diabetes On Its Ear with Revita DMR
Medical Devices and Diagnostics Industry
Thu, 06/11/20 - 12:13 pm
Fractyl Labs
diabetes
type 2 diabetes
Revita DMR
devices
Medtech
Sanofi culls pipeline dud, still looking to out-license unwanted later-stage meds
Fierce Biotech
Fri, 04/24/20 - 10:54 am
Sanofi
Regeneron
efpeglenatide
type 2 diabetes
FDA Revamps Safety Testing for new Type 2 Diabetes Drugs
RAPS.org
Mon, 03/9/20 - 11:12 pm
FDA
type 2 diabetes
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Pharmaceutical Business Review
Mon, 02/24/20 - 10:42 am
Eli Lilly
Trulicity
FDA
type 2 diabetes
Cardiovascular
Preclinical Data Shows Potential Path to Reverse Type-2 Diabetes and Liver Fibrosis
BioSpace
Tue, 02/11/20 - 10:41 am
Yale
type 2 diabetes
liver fibrosis
NDMA in Metformin: FDA Finds Low Levels in Only 2 of 10 Tested Products
RAPS.org
Tue, 02/4/20 - 10:23 am
NDMA
metformin
FDA
type 2 diabetes
diabetes
Novo Nordisk joins with UVA in diabetes digital simulation project
Pharmaforum
Fri, 12/20/19 - 12:08 pm
Novo Nordisk
UVA
R&D
type 2 diabetes
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Mon, 12/16/19 - 10:35 am
Jardiance
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
chronic heart failure
clinical trials
After Zantac scare, FDA targets generic metformin for carcinogen tests
Fierce Pharma
Thu, 12/5/19 - 11:45 pm
generics
FDA
type 2 diabetes
metformin
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
Tue, 12/3/19 - 09:50 am
AstraZeneca
diabetes
type 2 diabetes
heart failure
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
Tue, 11/5/19 - 10:22 am
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Tue, 11/5/19 - 10:21 am
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
type 2 diabetes
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Thu, 10/24/19 - 10:55 am
Eli Lilly
Trulicity
Taltz
immunology
type 2 diabetes
J&J's suffering Invokana scores new kidney disease nod. Can it turn sales around?
Fierce Pharma
Mon, 09/30/19 - 11:47 pm
JNJ
Invokana
diabetic kidney disease
FDA
type 2 diabetes
Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus
Fierce Pharma
Fri, 09/20/19 - 01:13 pm
Novo Nordisk
oral semaglutide
FDA
Rybelsus
type 2 diabetes
Novo, e-therapeutics extend Type 2 diabetes research pact to include new genomics tech
Fierce Biotech
Thu, 08/1/19 - 10:35 am
Novo Nordisk
e-therapeutics
drug discovery
type 2 diabetes
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »